Inventor · disambiguated record
David W. Griggs
Also filed as: GRIGGS DAVID · GRIGGS DAVID W · GRIGGS DAVID WILLIAM
8 granted patents·5 pending applications·63 citations·filing 2003–2023
84Inventor score
Top patents by PatentIndex Score
13 records- 0192US8716226B23,5 phenyl-substituted beta amino acid derivatives as integrin antagonistsUNIV SAINT LOUIS·Filed 2013·Granted May 6, 2014·14 cites·4 claims
- 0291US7452537B2P-cadherin antibodiesAGOURON PHARMA·Filed 2006·Granted Nov 18, 2008·40 cites·9 claims
- 0380US10035778B2Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonistsUNIV SAINT LOUIS·Filed 2017·Granted Jul 31, 2018·2 cites·20 claims
- 0476US9085606B2Beta amino acid derivatives as integrin antagonistsUNIV SAINT LOUIS·Filed 2013·Granted Jul 21, 2015·4 cites·18 claims
- 0574US7928214B2P-cadherin antibodiesAGOURON PHARMA·Filed 2008·Granted Apr 19, 2011·2 cites·12 claims
- 0664US2024115521A1Compounds for the treatment of mycobacterial diseasesUNIV SAINT LOUIS·Filed 2023·Application pending·0 cites
- 0763US2020199079A1Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonistsUNIV SAINT LOUIS·Filed 2020·Application pending·0 cites
- 0862US8974781B2P-cadherin antibodiesBAUER CHRISTOPHER TODD·Filed 2011·Granted Mar 10, 2015·1 cites·9 claims
- 0961US10577330B2Meta-azacyclic amino benzoic acid derivatives as pan integrin antagonistsUNIV SAINT LOUIS·Filed 2018·Granted Mar 3, 2020·0 cites·19 claims
- 1046US2021284638A1ALPHAvBETA1 INTEGRIN ANTAGONISTSUNIV SAINT LOUIS·Filed 2019·Application pending·0 cites
- 1144US11306084B2Integrin antagonistsUNIV SAINT LOUIS·Filed 2017·Granted Apr 19, 2022·0 cites·29 claims
- 1235US2004167067A1ESM-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the sameFiled 2003·Application pending·0 cites
- 1335US2003232367A1Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the sameFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →